Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2025-04-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于2024年度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's asset impairment provision for the fiscal year 2024. It details the amounts and methods of impairment provisions for various asset categories such as credit impairment, inventory, fixed assets, goodwill, and contract assets. The document also mentions the board's review and compliance with accounting standards and regulatory requirements. The length is about 2834 characters, which is relatively short and the document is an announcement rather than a full financial report. It does not contain comprehensive financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). It is a regulatory announcement about impairment provisions, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories and is not a full audit report or earnings release. Therefore, the classification is Regulatory Filings (RNS).
2025-04-24 Chinese
董事会对独董独立性评估的专项意见
Board/Management Information Classification · 95% confidence The document is a board announcement regarding the independence of the company's independent directors for the year 2024. It references compliance with regulatory guidelines and confirms the independence status of the directors. There is no financial data, no report attached or referenced as being published, and no mention of voting results or other report types. The content fits best under Board/Management Information (MANG) as it relates to board members and their qualifications.
2025-04-24 Chinese
关于召开2024年年度股东会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2024 Annual General Meeting (AGM) of 阳普医疗科技股份有限公司, including the date, time, location, voting procedures, agenda items, and proxy forms. It does not contain the actual annual report or financial statements but rather the announcement and logistical details for the upcoming AGM. The document length is about 4800 characters, which is consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2025-04-24 Chinese
董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee evaluating the performance of the external audit firm for the fiscal year 2024. It discusses the audit firm's qualifications, the audit procedures performed, communication with management, and the committee's supervision of the audit process. It references the audit of the 2024 annual financial statements and the issuance of an unqualified audit opinion. The document is not the annual report itself but a standalone report on the audit firm's performance and the audit committee's oversight. It fits the definition of an Audit Report / Information (AR) as it is a standalone audit-related report, not the full annual report or an announcement of a report. The document length is 2324 characters, which is relatively short but contains substantive audit evaluation content, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-04-24 Chinese
2024年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as "阳普医疗科技股份有限公司2024 年年度报告摘要" which translates to "Yangpu Medical Technology Co., Ltd. 2024 Annual Report Summary." It contains detailed financial data for the year 2024, including total assets, net profit, revenue, earnings per share, and other financial indicators. It also includes business descriptions, product lines, shareholder information, and audit opinions. The document explicitly states it is a summary of the annual report and references the full annual report for comprehensive details. The length of the document (9215 characters) and the presence of substantive financial data and business overview indicate this is a financial report rather than a mere announcement. Therefore, this document is best classified as an Annual Report (10-K equivalent). FY 2024
2025-04-24 Chinese
2024年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2024年度监事会工作报告" which translates to "2024 Supervisory Board Work Report". It details the supervisory board's activities, meetings, oversight of financial and operational matters, internal controls, and governance for the year 2024. It includes specific references to the supervisory board's review of the annual report, financial statements, internal controls, and other governance matters. The document is a detailed report on the supervisory board's work and oversight rather than a full annual report or audit report itself. It is not a short announcement or certification but a substantive report on management and governance oversight. This fits best under the category of Management Reports (MDA), which covers management's detailed explanation of financial results, business trends, and outlook, including supervisory board reports on governance and oversight.
2025-04-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.